Global Immune Repertoire Sequencing Market 2020 By Product Type [Analytical Software, Assay Kits, Instruments, Services and others],By Application [Autoimmune Diseases, Biomarker Discovery, Cancer Immunotherapy, Infectious Diseases, Transplant Rejection and Tolerance and Vaccine Development and Efficacy], By End User[Diagnostic Labs, Biotechnology and Pharmaceutical Companies, Academic and Research Institutes and Others]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Immune Repertoire Sequencing Market is valued at USD 131.2 Million in 2019 and expected to reach USD 215.1 Million by 2026 with the CAGR of 7.33 % over the forecast period.
Scope of the report
This report analyses the global market for Immune Repertoire Sequencing. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players
Adaptive Biotechnologies, Agilent Technologies, Inc., ArcherDX, Inc., Atreca, Inc., CD Genomics, Illumina Inc., Oxford Nanopore Technologies, Ltd., Pacific Biosciences, Qiagen N.V., Roche Holding AG, Takara Bio, Inc., Thermo Fisher Scientific, Inc. and others
Above mentioned companies were scrutinized to assess competitive landscape of global Immune Repertoire Sequencing market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period: (2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Million
This Immune Repertoire Sequencing market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Product Type
o Analytical Software
o Assay Kits
o Instruments
o Services
• Application
o Autoimmune Diseases
o Biomarker Discovery
o Cancer Immunotherapy
o Infectious Diseases
o Transplant Rejection and Tolerance
o Vaccine Development and Efficacy
• End User
o Diagnostic Labs
o Biotechnology and Pharmaceutical Companies
o Academic and Research Institutes
o Others
Report Coverage
• An overview of the global Immune Repertoire Sequencing market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Immune Repertoire Sequencing market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Immune Repertoire Sequencing market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Immune Repertoire Sequencing Market Report
• What is the impact of COVID 19 epidemic on the global Immune Repertoire Sequencing market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Immune Repertoire Sequencing market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Immune Repertoire Sequencing market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?
Table of Contents
1. Introduction
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
3.1. Market Definition
3.2. Market Scope
3.3. Market Drivers
3.4. Market Restraints
3.5. Market Opportunities and Trends
3.6. Porter’s five force analysis
3.7. SWOT Analysis
3.8. PEST Analysis
3.9. Patent Analysis
3.10. Impact of COVID 19 on Global Immune Repertoire Sequencing Market
4. Immune Repertoire Sequencing Market, By Product Type, Market Size and Forecast 2016 -2026 (USD Million)
4.1. Global Immune Repertoire Sequencing Market By Product Type, 2016 -2026 (USD Million)
4.1.1. Global Immune Repertoire Sequencing Market By Analytical Software
4.1.2. Global Immune Repertoire Sequencing Market By Assay Kits
4.1.3. Global Immune Repertoire Sequencing Market By Instruments
4.1.4. Global Immune Repertoire Sequencing Market By Services
4.2. Global Immune Repertoire Sequencing Market By Product Type Share, 2016 -2026 (%)
5. Immune Repertoire Sequencing Market, By End User, Market Size and Forecast 2016 -2026 (USD Million)
5.1. Global Immune Repertoire Sequencing Market By End User, 2016 -2026 (USD Million)
5.1.1. Global Immune Repertoire Sequencing Market By Diagnostic Labs
5.1.2. Global Immune Repertoire Sequencing Market By Biotechnology and Pharmaceutical Companies
5.1.3. Global Immune Repertoire Sequencing Market By Academic and Research Institutes
5.1.4. Global Immune Repertoire Sequencing Market By Others
5.2. Global Immune Repertoire Sequencing Market By End User Share, 2016 -2026 (%)
6. Immune Repertoire Sequencing Market, By Application, Market Size and Forecast 2016 -2026 (USD Million)
6.1. Global Immune Repertoire Sequencing Market By Application, 2016 -2026 (USD Million)
6.1.1. Global Immune Repertoire Sequencing Market By Autoimmune Diseases
6.1.2. Global Immune Repertoire Sequencing Market By Biomarker Discovery
6.1.3. Global Immune Repertoire Sequencing Market By Cancer Immunotherapy
6.1.4. Global Immune Repertoire Sequencing Market By Infectious Diseases
6.1.5. Global Immune Repertoire Sequencing Market By Transplant Rejection and Tolerance
6.1.6. Global Immune Repertoire Sequencing Market By Vaccine Development and Efficacy
6.2. Global Immune Repertoire Sequencing Market By Application Share, 2016 -2026 (%)
7. Immune Repertoire Sequencing Market, By Region Market Size and Forecast 2016 -2026
7.1. NORTH AMERICA
7.1.1. Key Findings
7.1.2. Impact of COVID 19
7.1.3. Key market trends, growth factors and opportunities
7.1.4. North America Immune Repertoire Sequencing Market by Country 2016 -2026 (USD Million)
7.1.5. North America Immune Repertoire Sequencing Market By Product Type 2016 -2026 (USD Million)
7.1.6. North America Immune Repertoire Sequencing Market By Application 2016 -2026 (USD Million)
7.1.7. North America Immune Repertoire Sequencing Market By End User 2016 -2026 (USD Million)
7.2. EUROPE
7.2.1. Key Findings
7.2.2. Impact of COVID 19
7.2.3. Key market trends, growth factors and opportunities
7.2.4. Europe Immune Repertoire Sequencing Market by Country 2016 -2026 (USD Million)
7.2.5. Europe Immune Repertoire Sequencing Market By Product Type 2016 -2026 (USD Million)
7.2.6. Europe Immune Repertoire Sequencing Market By Application 2016 -2026 (USD Million)
7.2.7. Europe Immune Repertoire Sequencing Market By End User 2016 -2026 (USD Million)
7.3. ASIA PACIFIC
7.3.1. Key Findings
7.3.2. Impact of COVID 19
7.3.3. Key market trends, growth factors and opportunities
7.3.4. Asia Pacific Immune Repertoire Sequencing Market by Country 2016 -2026 (USD Million)
7.3.5. Asia Pacific Immune Repertoire Sequencing Market By Product Type 2016 -2026 (USD Million)
7.3.6. Asia Pacific Immune Repertoire Sequencing Market By Application 2016 -2026 (USD Million)
7.3.7. Asia Pacific Immune Repertoire Sequencing Market By End User 2016 -2026 (USD Million)
7.4. LATIN AMERICA
7.4.1. Key Findings
7.4.2. Impact of COVID 19
7.4.3. Key market trends, growth factors and opportunities
7.4.4. Latin America Immune Repertoire Sequencing Market by Country 2016 -2026 (USD Million)
7.4.5. Latin America Immune Repertoire Sequencing Market By Product Type 2016 -2026 (USD Million)
7.4.6. Latin America Immune Repertoire Sequencing Market By Application 2016 -2026 (USD Million)
7.4.7. Latin America Immune Repertoire Sequencing Market By End User 2016 -2026 (USD Million)
7.5. MIDDLE EAST AND AFRICA
7.5.1. Key Findings
7.5.2. Impact of COVID 19
7.5.3. Key market trends, growth factors and opportunities
7.5.4. Middle East and Africa Immune Repertoire Sequencing Market by Country 2016 -2026 (USD Million)
7.5.5. Middle East and Africa Immune Repertoire Sequencing Market By Product Type 2016 -2026 (USD Million)
7.5.6. Middle East and Africa Immune Repertoire Sequencing Market By Application 2016 -2026 (USD Million)
7.5.7. Middle East and Africa Immune Repertoire Sequencing Market By End User 2016 -2026 (USD Million)
8. Competitive Landscape Analysis
8.1. Global Immune Repertoire Sequencing Market Company Revenue, (USD Million), 2016-2019
8.2. Global Immune Repertoire Sequencing Market Company Share, (%), 2016-2019
9. Company Profiles
9.1. Adaptive Biotechnologies
9.2. Agilent Technologies, Inc.
9.3. ArcherDX, Inc.
9.4. Atreca, Inc.
9.5. CD Genomics
9.6. Illumina Inc.
9.7. Oxford Nanopore Technologies, Ltd.
9.8. Pacific Biosciences
9.9. Qiagen N.V.
9.10. Roche Holding AG
9.11. Takara Bio, Inc.
9.12. Thermo Fisher Scientific, Inc.
9.13. Others
10. Appendix
11. List of Tables
12. List of Figures